insurance

First Opinion By Kip Sullivan and James G. Kahn

Accountable care organizations don’t cut costs. It’s time to stop the managed care experiment

First Opinion By Laura Specker Sullivan

The ethical implications of who judges what’s ‘necessary’ when it comes to emergency care

Health By Andrew Joseph and Rachel Cohrs

Alzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm

First Opinion By Josh Marx

Outdated Medicare rules threaten older Americans’ access to home medical equipment

Opinions+ By John Freedman

The many benefits of expanding the reach of state all-payer claims databases

First Opinion By Erin E. Trish, Eugene Lin and Matthew Fiedler

Congress should end dialysis companies’ third-party games with insurance coverage

First Opinion By Abigail Hardin

Fee or free? The services hospital-based psychologists provide are ‘priceless’

First Opinion By Sheldon Whitehouse and Sherrod Brown

Covid-19 makes ‘brutally clear’ why we need to add a public option for health insurance

First Opinion By Steve Cohen

Instead of prior authorization, insurers should go back to the old ‘pay-and-chase’ model

First Opinion By Lanhee J. Chen, Tom Church and Daniel L. Heil

A public option for health insurance could be a disaster, especially in times of crisis

First Opinion By Sara R. Collins

The number of Americans without health insurance has been trending up. Let’s turn it down again

First Opinion By Brian Barnett

Who’s choosing Americans’ medications — doctors or insurers? The bane of prior authorization

First Opinion By Jasmine L. Travers

We need long-term solutions for older Americans’ long-term care

First Opinion By Robin Feldman

Make list price the touchstone for drug pricing across the supply chain

Politics By Lev Facher

Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs

First Opinion By Rebecca Kolins Givan

President Trump is benefiting from single-payer, single-provider health care. We all should

First Opinion By Andrew Parece and Matthew Majewski

Instead of eliminating drug rebates, use average sales price to set co-insurance levels

First Opinion By Gretchen Jacobson

Covid-19 is accelerating the Medicare trust fund’s dive toward insolvency

First Opinion By Jackson Williams

Seeing the ‘deep pocket’ effect when insurers pay for health care

Special Report By Erin Brodwin and Casey Ross

Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO

Business By Casey Ross

Gawande says leaving Haven CEO job will allow him to focus on Covid-19

Business By Casey Ross and Erin Brodwin

Atul Gawande to depart as CEO of splashy health venture. Is it ‘a death knell’?

First Opinion By Eric Schneider

Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care

Pharmalot By Ed Silverman

Americans with employer coverage saw growth in drug spending outpace other medical costs

First Opinion By Dorothy Pomerantz

I was fortunate to get post-23andMe genetic counseling. Everyone should have that option